# SCD Stem Cell Mobilization and Apheresis Using Motixafortide

> **NCT06442761** · PHASE1 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Motixafortide

## Key facts

- **NCT ID:** NCT06442761
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2028-01
- **Final completion:** 2028-07
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06442761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06442761, "SCD Stem Cell Mobilization and Apheresis Using Motixafortide". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06442761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*